Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Michael Conn

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2010
Salt bridge integrates GPCR activation with protein traffickingJo Ann Janovick, P Michael Conn
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 11, 2015
Pharmacoperones: targeting therapeutics toward diseases caused by protein misfoldingAlfredo Ulloa-Aguirre, Teresa Zariñán, P Michael Conn
Endocrine|January 8, 2004
Evolved regulation of gonadotropin-releasing hormone receptor cell surface expressionJo Ann Janovick, Alfredo Ulloa-Aguirre, P Michael Conn
Molecular and Cellular Endocrinology|March 20, 2003
A Galphas mutation (D229S) differentially effects gonadotropin-releasing hormone receptor regulation by RGS10, RGS3 and RGS3TCecilia Castro-Fernández, Shaun P Brothers, P Michael Conn
Plos One|August 6, 2011
Therapeutic rescue of misfolded mutants: validation of primary high throughput screens for identification of pharmacoperone drugsJo Ann Janovick, Byung S Park, P Michael Conn
Methods in Enzymology|January 29, 2013
Therapeutic rescue of misfolded/mistrafficked mutants: automation-friendly high-throughput assays for identification of pharmacoperone drugs of GPCRsDavid C Smithson, Jo Ann Janovick, P Michael Conn
The Journal of Clinical Endocrinology and Metabolism|July 11, 2002
Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic targetJo Ann Janovick, Guadalupe Maya-Nunez, P Michael Conn
The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
Receptor-misrouting: an unexpectedly prevalent and rescuable etiology in gonadotropin-releasing hormone receptor-mediated hypogonadotropic hypogonadismAlfredo Leaños-Miranda, Jo Ann Janovick, P Michael Conn
Pharmacological Research|November 26, 2013
"Pharmacoperone": what's in a word?P Michael Conn, Alfredo Ulloa-Aguirre, Jo Ann Janovick
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
Unexpected effects of epitope and chimeric tags on gonadotropin-releasing hormone receptors: implications for understanding the molecular etiology of hypogonadotropic hypogonadismShaun P Brothers, Jo Ann Janovick, P Michael Conn
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2010
Salt bridge integrates GPCR activation with protein traffickingJo Ann Janovick, P Michael Conn
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|April 11, 2015
Pharmacoperones: targeting therapeutics toward diseases caused by protein misfoldingAlfredo Ulloa-Aguirre, Teresa Zariñán, P Michael Conn
Endocrine|January 8, 2004
Evolved regulation of gonadotropin-releasing hormone receptor cell surface expressionJo Ann Janovick, Alfredo Ulloa-Aguirre, P Michael Conn
Molecular and Cellular Endocrinology|March 20, 2003
A Galphas mutation (D229S) differentially effects gonadotropin-releasing hormone receptor regulation by RGS10, RGS3 and RGS3TCecilia Castro-Fernández, Shaun P Brothers, P Michael Conn
Plos One|August 6, 2011
Therapeutic rescue of misfolded mutants: validation of primary high throughput screens for identification of pharmacoperone drugsJo Ann Janovick, Byung S Park, P Michael Conn
Methods in Enzymology|January 29, 2013
Therapeutic rescue of misfolded/mistrafficked mutants: automation-friendly high-throughput assays for identification of pharmacoperone drugs of GPCRsDavid C Smithson, Jo Ann Janovick, P Michael Conn
The Journal of Clinical Endocrinology and Metabolism|July 11, 2002
Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic targetJo Ann Janovick, Guadalupe Maya-Nunez, P Michael Conn
The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
Receptor-misrouting: an unexpectedly prevalent and rescuable etiology in gonadotropin-releasing hormone receptor-mediated hypogonadotropic hypogonadismAlfredo Leaños-Miranda, Jo Ann Janovick, P Michael Conn
Pharmacological Research|November 26, 2013
"Pharmacoperone": what's in a word?P Michael Conn, Alfredo Ulloa-Aguirre, Jo Ann Janovick
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
Unexpected effects of epitope and chimeric tags on gonadotropin-releasing hormone receptors: implications for understanding the molecular etiology of hypogonadotropic hypogonadismShaun P Brothers, Jo Ann Janovick, P Michael Conn
Pageof 11